Institutional
July 27, 2017
São Paulo Court allows the marketing of generic drug while the patent applications for the reference drug are still pending
Allergan had obtained an injunction preventing the marketing of a generic drug for Combingan®. However, such injunction was revoked because the Trial Court understood in a decision on the merits the owner of pending patent applications does not enjoy exclusive rights. The decision may be subject to an appeal.
Click on Download to access the full text of the decision.
Back
Share:
Last related news
December 13, 2024
We present you KL Index: the new platform about Intellectual Property Law evolution in Brazil!
We present you KL Index, a tool that easily provides historical data to analyze the growth of Intellectual Property (IP) in the … We present you KL Index: the new platform about Intellectual Property Law evolution in Brazil!
December 6, 2024
Tarso Machado participates in FICPI’s webinar as a Rising IP Star
Our partner Tarso Machado will participate in the international webinar “Rising IP Stars”, promoted by FICPI – International Federation of Intellectual Property … Tarso Machado participates in FICPI’s webinar as a Rising IP Star
November 28, 2024
We are ranked on Análise Advocacia 2025
We are honored to announce that we have been ranked by Análise Advocacia – 2025 Edition among the most admired firms in … We are ranked on Análise Advocacia 2025